CTI BioPharma develops drugs that leverage the its expertise in blood-related cancers to address unmet medical needs and find therapies that are less toxic.
- Year invested 2018
- Investment Stage Public/PIPES
- Sectors
- Investment Status Current
- Associated Team
- Website ctibiopharma.com/
- Company Status IPO/Public